Asked by: Peter Dowd (Labour - Bootle)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, if he will meet with Parkinson’s UK and the hon. Member for Bootle to discuss the experience of people with Parkinson’s in the social security system.
Answered by Mims Davies - Minister of State (Department for Work and Pensions)
The Work Capability Assessment (WCA) assesses individuals against a set of descriptors to determine how their health condition or disability affects their ability to work. The WCA takes into account the functional effects of fluctuating and degenerative conditions such as Parkinson’s. A key principle is that the WCA considers the impact that a person’s disability or health condition has on them, not the condition itself.
Claimants with the most severe health conditions and disabilities whose condition is unlikely to ever improve are no longer routinely reassessed.
From 2025, we are reforming the WCA to reflect new flexibilities in the labour market and greater employment opportunities for disabled people and people with health conditions, whilst maintaining protections for those with the most significant conditions. Claimants who currently have no work-related requirements, except in some very limited circumstances, will not be reassessed or lose benefit because of these changes.
When making decisions on changes to the WCA, we carefully considered over 1300 consultation responses, including from disabled people, people with health conditions, and the organisations that represent and support them. We also engaged directly with clinical experts, employer groups and disability organisations across the country.
With these changes to the WCA criteria, 371,000 fewer people will be assessed as having limited capability for work and work-related activity by 2028-29 and will receive personalised support to help them move closer to employment. A further 29,000 individuals will be found fit for work by 2028-29 and will receive more intensive support to search for and secure work than would be the case under the current WCA rules. These figures are not based on specific conditions. This is because the WCA considers the impact that a person’s disability or health condition has on their ability to work, not the condition itself.
The department routinely engages with a wide range of organisations that represent and support disabled people and people with health conditions, including people living with Parkinson’s disease.
Asked by: Mary Glindon (Labour - North Tyneside)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, if he will make an assessment of the potential impact of proposed changes to Work Capability Assessments on people with Parkinson's disease.
Answered by Mims Davies - Minister of State (Department for Work and Pensions)
The Work Capability Assessment (WCA) assesses individuals against a set of descriptors to determine how their health condition or disability affects their ability to work. The WCA takes into account the functional effects of fluctuating and degenerative conditions such as Parkinson’s. A key principle is that the WCA considers the impact that a person’s disability or health condition has on them, not the condition itself.
Claimants with the most severe health conditions and disabilities whose condition is unlikely to ever improve are no longer routinely reassessed.
From 2025, we are reforming the WCA to reflect new flexibilities in the labour market and greater employment opportunities for disabled people and people with health conditions, whilst maintaining protections for those with the most significant conditions. Claimants who currently have no work-related requirements, except in some very limited circumstances, will not be reassessed or lose benefit because of these changes.
When making decisions on changes to the WCA, we carefully considered over 1300 consultation responses, including from disabled people, people with health conditions, and the organisations that represent and support them. We also engaged directly with clinical experts, employer groups and disability organisations across the country.
With these changes to the WCA criteria, 371,000 fewer people will be assessed as having limited capability for work and work-related activity by 2028-29 and will receive personalised support to help them move closer to employment. A further 29,000 individuals will be found fit for work by 2028-29 and will receive more intensive support to search for and secure work than would be the case under the current WCA rules. These figures are not based on specific conditions. This is because the WCA considers the impact that a person’s disability or health condition has on their ability to work, not the condition itself.
The department routinely engages with a wide range of organisations that represent and support disabled people and people with health conditions, including people living with Parkinson’s disease.
Asked by: Peter Dowd (Labour - Bootle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether the NHS Long Term Workforce Plan will include steps to help tackle regional variations in access to Parkinson’s specialist care.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The NHS Long Term Workforce Plan (LTWP) sets out the steps the National Health Service and its partners need to take to deliver an NHS workforce that meets the changing needs of the population over the next 15 years. It covers the majority of NHS workforce groups, including those working on Parkinson’s disease. The LTWP commits to working closely with systems to consider the best approaches to reviewing the geographical distribution of training posts for wider professional groups.
Asked by: Mary Glindon (Labour - North Tyneside)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will amend the NHS long-term workforce plan to help tackle regional variations in access to Parkinson’s specialist care.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The NHS Long Term Workforce Plan (LTWP) sets out the steps the National Health Service and its partners need to take to deliver an NHS workforce that meets the changing needs of the population over the next 15 years. It covers the majority of NHS workforce groups, including those working on Parkinson’s disease. The LTWP commits to working closely with systems to consider the best approaches to reviewing the geographical distribution of training posts for wider professional groups.
Apr. 12 2024
Source Page: Non-technical summaries granted in 2024Found: The development of novel therapies (including cell and gene based approaches) for Parkinson's and Huntington's
Apr. 11 2024
Source Page: Funding for Parkinson's Disease: FOI releaseFound: Funding for Parkinson's Disease: FOI release
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential merits of issuing warm home prescriptions to patients with Parkinson's disease.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
We have made no specific assessment. The Government recognises that warm home prescription schemes can be effective in helping to protect vulnerable people and households from the health impacts of living in a cold home. These schemes are good examples of local collaboration between the National Health Service, local government, and other partners.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to help ensure patients diagnosed with Parkinson's disease receive an appointment with a specialist within six weeks.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The National Institute for Health and Care Excellence’s (NICE) guidance, Parkinson’s disease: Diagnosis and management in primary and secondary care, updated in 2017, sets out best practice for clinicians in the identification and treatment of Parkinson’s disease in line with the latest available evidence. The guidance states that if Parkinson’s disease is suspected, people should be referred quickly and without treatment to a specialist with expertise in the differential diagnosis of this condition.
We expect integrated care boards (ICBs) and National Health Service trusts to have due regard to relevant NICE guidelines. It is the responsibility of ICBs to make available the appropriate provision to meet the health and care needs of their local population, in line with these NICE guidelines.
More generally, cutting waiting lists is one of the Prime Minister’s top priorities. We are making good progress on tackling the longest waits, to ensure patients get the care they need when they need it. Ambitions to eliminate long waits were set out in the elective recovery plan, with the overall aim of eliminating waits of over a year for elective care, by March 2025.
To facilitate this across elective services, we are increasing activity, with plans to spend more than £8 billion from 2022/23 to 2024/25. This includes expanding capacity through the creation of a new network of community diagnostic centres, and maximising all available independent sector capacity.
Mar. 14 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023Found: Burning sensation 4 0 Formication 1 0 Hypoaesthesia 17 0 Paraesthesia 27 0 Parkinson's
Mar. 14 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023Found: coronary artery bypass (1), acute my ocardial infarct ion (1), alcoholic (1), deficiency anaem ia (1), Parkinson's